Namibia's Directorate of Veterinary Services (DVS) has updated control measures to combat the ongoing outbreak of Lumpy Skin ...
Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...
The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...
Bharat Biotech's group company, Biovet, has launched the world's first-ever Lumpy Skin Disease (LSD) vaccine, Biolumpivaxin, ...
Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.
In the last two years, around 200,000 cattle have died, millions lost their milk production capabilities due to LSD ...
Bharat Biotech’s Biovet secures regulatory nod for Biolumpivaxin, developed with ICAR, to protect cattle and buffaloes from LSD ...
Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...
The Central Drug Standards Control Organization (CDSCO) has granted license to Biolumpivaxin -- the country’s first vaccine ...
Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and naturally infected dairy cattle ...
The vaccine Biolumpivaxin, developed jointly by the Indian Council of Agricultural Research (ICAR) and Biovet, will enable ...